The Research, Scholarship, and Artistic Achievement Awards nomination deadline has been extended to May 31, 2024. Click here for more information.

Compositions and Methods for Treating Vascular Disorders


Tulane is actively seeking commercial entities to further develop and commercialize our novel composition of viral vectors for impairment of pathological angiogenesis


Anti-angiogenic therapy for treatment of age-related macular degeneration, atherosclerosis, diabetic retinopathy, and cancer

Current Work

Proof-of-concept studies completed.


Qinbo Zhou, PhD

Intellectual Property

Available For

Exclusive License in a Field
Non-exclusive License
Scientific Collaboration

For more information, please contact: